Full blood count, liver and renal function, and phosphate on tenofovir
then every 3 months
tests per year, UK, before starting, at 4 weeks, then every 3 months
“Monitor full blood count, liver function (including bilirubin, albumin and ALT), renal function (including urea and electrolyte levels and urine protein/creatinine ratio), and phosphate levels in people with compensated liver disease before starting tenofovir disoproxil, 4 weeks after starting treatment and then every 3 months to detect adverse effects.”
NICE CG165, Hepatitis B (chronic): diagnosis and management, recommendation 1.6.15, 2017-10-20
- Kind of source
- Clinical guideline
- Read on
- 2026-11-06
- Daily check
- Quote found at the source on 2026-11-06
- What to know
- Safety monitoring for people with compensated liver disease on tenofovir disoproxil.
Used in
Kept as evidence; no figure on the platform is computed from it yet.